AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...
AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...
Nose and Throat Clinic, Ninewells Hospital University of Dundee in Scotland, UK, and co-primary investigator in the trial, said: "Patients diagnosed with nasal polyps continue to experience ...
A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.
Woman's World on MSN4d
Dealing with a Blocked Nostril? Here’s How to Clear It Fast!Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...
CRSwNP is an inflammatory condition which results in the growth of nasal polyps in the nose that can sometimes require surgical intervention. Around 40% of cases are uncontrolled and – in severe ...
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
THOUSAND OAKS, Calif., Nov. 7, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line ...
GlobalData on MSN4d
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trialA Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback